Changeflow GovPing Pharma & Drug Safety City of Hope Patents Phosphorothioated Oligodeo...
Routine Notice Added Final

City of Hope Patents Phosphorothioated Oligodeoxynucleotide Compounds and Compositions

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3316894A1 for City of Hope covering phosphorothioated oligodeoxynucleotide compounds and pharmaceutical compositions for therapeutic use. The application classifies under IPC codes C12N 15/113 and A61K 31/713 relating to oligonucleotides and nucleic acid preparations. The publication establishes a priority date and makes the application available for opposition.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The EPO published patent application EP3316894A1 for City of Hope covering phosphorothioated oligodeoxynucleotide compounds and pharmaceutical compositions for therapeutic use. The application classifies under multiple IPC codes including C12N 15/113 for nucleic acid preparations and A61K 31/713 for medicinal preparations containing oligonucleotides. Designated states cover all current EU member states plus extension states.

Affected parties include pharmaceutical manufacturers developing oligonucleotide-based therapeutics, biotech companies working with nucleic acid compounds, and research institutions conducting work in this technology space. The publication establishes a priority date of April 8, 2026 and makes the application available for third-party observation during the examination phase.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF

Publication EP3316894A1 Kind: A1 Apr 08, 2026

Applicants

City of Hope

Inventors

KORTYLEWSKI, Marcin, Tomasz, SWIDERSKI, Piotr, Marek, MOREIRA, Dayson, Friaca

IPC Classifications

C12N 15/113 20100101AFI20190515BHEP A61K 31/713 20060101ALI20190515BHEP A61K 31/7105 20060101ALI20190515BHEP C07H 21/04 20060101ALN20190515BHEP C07H 21/02 20060101ALN20190515BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3316894A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing IP licensing Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!